EXCO INTOUCH TO HOST WEBINAR DEMONSTRATING THE BENEFITS OF A WELL-DEFINED EPRO STRATEGY IN DRUG DEVELOPMENT
VODAFONE AND EXCO INTOUCH PARTNER TO DEVELOP A PATIENT REPORTED OUTCOMES SOLUTION THAT WILL TRANSFORM PATIENT ENGAGEMENT IN CLINICAL TRIALS
EXCO INTOUCH IS NAMED MICROSOFT MANAGED PARTNER WITHIN LIFE SCIENCES
PFIZER HEALTHCARE INFORMATICS DIRECTOR JOINS EXCO INTOUCH TO LEAD MHEALTH AND MOBILE PRODUCT STRATEGY
Exco InTouch Wins European Outsourcing Award for Second Year Running
Exco InTouch Wins Deloitte Technology Fast 50 Award in Recognition of Significant Growth
Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, today announced that it is a winner of the 2011 Deloitte Technology Fast 50. The awards, now in their 14th year, are an independent ranking of the 50 fastest-growing technology companies in the UK, based on percentage growth in revenue over five years.
Exco InTouch Secures Growth Investment from SEP
Mobile patient communication leader to use funds to accelerate growth strategy Leading growth equity and venture capital group Scottish Equity Partners (SEP) has led an initial £3m pound investment in Exco InTouch, the leading provider of mobile patient communication and management solutions for the pharmaceutical and healthcare sector.
Pfizer Selects Exco InTouch’s Novel eDiary Technologies to Initiate First Ever Patient-Centered Clinical Trial
Exco InTouch, has announced that its novel eDiary technologies have been selected by Pfizer, the world’s leading pharmaceutical company, as part of the first ever Participatory Patient-Centered (PPC) clinical trial. The pilot study will utilize Exco InTouch’s leading eDiary technologies to enable patients to participate regardless of location, age or proximity to site. Focusing on new Research on Electronic Monitoring of OAB Treatment Experience (REMOTE) for the treatment of overactive bladder, the study will mimic a previously completed trial in order to replicate the results and validate this novel approach.